|
KMID : 1033620160430030139
|
|
Clinical and Experimental Reproductive Medicine
2016 Volume.43 No. 3 p.139 ~ p.145
|
|
|
The meaning of anti-Mullerian hormone levels in patients at a high risk of poor ovarian response
|
|
Park Hyun-Jong
Lee Geun-Ho
Gong Du-Sik
Yoon Tae-Ki
Lee Woo-Sik
|
|
|
Abstract
|
|
|
|
Measurements of ovarian reserve play an important role in predicting the clinical results of assisted reproductive technology (ART). The ideal markers of ovarian reserve for clinical applications should have high specificity in order to determine genuine poor responders. Basal follicle-stimulating hormone levels, antral follicle count, and serum anti-Mullerian hormone (AMH) levels have been suggested as ovarian reserve tests that may fulfill this requirement, with serum AMH levels being the most promising parameter. Serum AMH levels have been suggested to be a predictor of clinical pregnancy in ART for older women, who are at a high risk for decreased ovarian response. We reviewed the prognostic significance of ovarian reserve tests for patients undergoing ART treatment, with a particular focus on the significance of serum AMH levels in patients at a high risk of poor ovarian response.
|
|
|
KEYWORD
|
|
|
Anti-Mullerian hormone, Fertilization in vitro, Infertility, Pregnancy rate
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|